Editorial: Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?
Authors:
Open Access
- 17 October 2023
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1265314
Abstract
Editorial: Dysbiosis, obesity, and inflammation: interrelated phenomena causes or effects of metabolic syndrome?Keywords
This publication has 29 references indexed in Scilit:
- Gut microbiota, obesity and diabetesPostgraduate Medical Journal, 2016
- Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndromeJournal of Pain Research, 2015
- Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra‐performance liquid chromatography/mass spectrometryBiomedical Chromatography, 2014
- Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: A 4year retrospective longitudinal studyMetabolism, 2014
- Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic painInflammopharmacology, 2013
- Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical ImplicationsCurrent Nutrition & Food Science, 2013
- Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2The Journal of Nutrition, 2011
- Original Article: Peroxisome proliferator‐activated receptor and AMP‐activated protein kinase agonists protect against lethal influenza virus challenge in miceInfluenza and Other Respiratory Viruses, 2010
- Body-Mass Index and Symptoms of Gastroesophageal Reflux in WomenNew England Journal of Medicine, 2006
- Obesity Is an Independent Risk Factor for GERD Symptoms and Erosive EsophagitisAmerican Journal of Gastroenterology, 2005